Shares Held by Insiders

Fully Diluted Shares Held by Insiders

Date

Name

Buy/Sell

$ Value

# Shares

Avg. Price

Title

Chief Regulatory Officer

Chief Commercial Officer

Chief Financial Officer

Chief Corp. Affairs Officer

Chief Executive Officer

Chief Medical Officer

Chief Scientific Officer

Chief Legal Officer

Chief Human Resources Officer

Chief Business Development Off

Neurocrine Biosciences, Inc. discovers, develops, and markets pharmaceuticals for neurological, endocrine, and psychiatric disorders. The company's portfolio includes treatments for tardive dyskinesia, Parkinson's disease, endometriosis, and uterine fibroids, as well as clinical programs in various therapeutic areas. Its products include INGREZZA and DYSVAL, for the treatment of tardive dyskinesia. The company's commercial products include ONGENTYS, used as an adjunctive therapy to levodopa/DOPA decarboxylase inhibitors for patients with Parkinson's disease; ORILISSA for the management of moderate to severe endometriosis pain in women; and ORIAHNN, a non-surgical oral medication option for the management of heavy menstrual bleeding associated with uterine fibroids in pre-menopausal women, as well as ALKINDI SPRINKLE, for the treatment of pediatric adrenal insufficiency. Its product candidates in clinical development include NBI-921352 for treating pediatric patients, as well as adult focal epilepsy indications; and NBI-827104 to treat rare pediatric epilepsy and essential tremor. The company's products in clinical development also comprise NBI-1065845 for the treatment of major depressive disorder; NBI-1065846 for treating anhedonia in major depressive disorder; and NBI-1117568 for the treatment of schizophrenia. It has license and collaboration agreements with Heptares Therapeutics Limited; Takeda Pharmaceutical Company Limited; Idorsia Pharmaceuticals Ltd; Xenon Pharmaceuticals Inc.; Voyager Therapeutics, Inc.; BIAL Ã‚â€“ Portela & Ca, S.A.; Mitsubishi Tanabe Pharma Corporation; Sentia Medical Sciences Inc.; and AbbVie Inc. The company was incorporated in 1992 and is headquartered in San Diego, California.

Neurocrine Biosciences, Inc. discovers, develops, and markets pharmaceuticals for neurological, endocrine, and psychiatric disorders.

Datesorted ascending	Name	Buy/Sell	$ Value	# Shares	Avg. Price	Title
2024-05-06	Premium	sold	Premium	Premium	Premium	Chief Regulatory Officer
2024-05-06	Premium	acquired	Premium	Premium	Premium	Chief Regulatory Officer
2024-04-15	Premium	acquired	Premium	Premium	Premium	Chief Commercial Officer
2024-04-15	Premium	sold	Premium	Premium	Premium	Chief Commercial Officer
2024-04-01	Premium	acquired	Premium	Premium	Premium	Chief Regulatory Officer
2024-04-01	Premium	sold	Premium	Premium	Premium	Chief Regulatory Officer
2024-03-21	Premium	acquired	Premium	Premium	Premium	Chief Regulatory Officer
2024-03-21	Premium	sold	Premium	Premium	Premium	Chief Regulatory Officer
2024-03-14	Premium	sold	Premium	Premium	Premium	-
2024-03-14	Premium	acquired	Premium	Premium	Premium	Chief Commercial Officer
2024-03-14	Premium	acquired	Premium	Premium	Premium	-
2024-03-14	Premium	sold	Premium	Premium	Premium	Chief Commercial Officer
2024-03-13	Premium	sold	Premium	Premium	Premium	Chief Regulatory Officer
2024-03-13	Premium	acquired	Premium	Premium	Premium	Chief Regulatory Officer
2024-03-13	Premium	acquired	Premium	Premium	Premium	-
2024-03-13	Premium	sold	Premium	Premium	Premium	-
2024-03-11	Premium	acquired	Premium	Premium	Premium	-
2024-03-11	Premium	acquired	Premium	Premium	Premium	Chief Regulatory Officer
2024-03-11	Premium	sold	Premium	Premium	Premium	Chief Regulatory Officer
2024-03-11	Premium	sold	Premium	Premium	Premium	-
2024-03-08	Premium	sold	Premium	Premium	Premium	Chief Regulatory Officer
2024-03-08	Premium	sold	Premium	Premium	Premium	-
2024-03-08	Premium	acquired	Premium	Premium	Premium	Chief Regulatory Officer
2024-03-08	Premium	acquired	Premium	Premium	Premium	-
2024-02-29	Premium	acquired	Premium	Premium	Premium	Chief Regulatory Officer

NBIX - Neurocrine Biosciences Inc Stock Price, Fair Value and News

Latest Insider Trading transactions for NBIX